Vemurafenib:Radiation Use During Vemurafenib Treatment
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Vemurafenib (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions
- 22 May 2017 Status changed from not yet recruiting to withdrawn prior to enrolment due to Competing Trials.
- 22 May 2017 Status changed from not yet recruiting to withdrawn prior to enrolment due to Competing Trials.
- 20 Sep 2016 Planned End Date changed from 1 Aug 2020 to 1 Aug 2022.